INS and type 2 diabetes mellitus: Since 2005, with the advent of genome-wide association studies (GWAS), the number of genetic loci known to influence type 2 diabetes risk and/or related quantitative glycaemic measures (e.g. glucose, insulin, HbA1c levels) has surged.